Advertisement
Research Article

Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa

  • Roger H. Brookes,

    Affiliation: Bacterial Diseases Programme, Tuberculosis Division, Medical Research Council Laboratories, Fajara, Banjul, The Gambia

    X
  • Philip C. Hill,

    Affiliation: Bacterial Diseases Programme, Tuberculosis Division, Medical Research Council Laboratories, Fajara, Banjul, The Gambia

    X
  • Patrick K. Owiafe,

    Affiliation: Bacterial Diseases Programme, Tuberculosis Division, Medical Research Council Laboratories, Fajara, Banjul, The Gambia

    X
  • Hannah B. Ibanga,

    Affiliation: Bacterial Diseases Programme, Tuberculosis Division, Medical Research Council Laboratories, Fajara, Banjul, The Gambia

    X
  • David J. Jeffries,

    Affiliation: Bacterial Diseases Programme, Tuberculosis Division, Medical Research Council Laboratories, Fajara, Banjul, The Gambia

    X
  • Simon A. Donkor,

    Affiliation: Bacterial Diseases Programme, Tuberculosis Division, Medical Research Council Laboratories, Fajara, Banjul, The Gambia

    X
  • Helen A. Fletcher,

    Affiliation: Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom

    X
  • Abdulrahman S. Hammond,

    Affiliation: Bacterial Diseases Programme, Tuberculosis Division, Medical Research Council Laboratories, Fajara, Banjul, The Gambia

    X
  • Christian Lienhardt,

    Affiliation: Institut de Recherche pour le Développement, Paris, France

    X
  • Richard A. Adegbola,

    Affiliation: Bacterial Diseases Programme, Tuberculosis Division, Medical Research Council Laboratories, Fajara, Banjul, The Gambia

    X
  • Helen McShane mail,

    helen.mcshane@ndm.ox.ac.uk

    Affiliation: Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom

    X
  • Adrian V. S. Hill

    Affiliations: Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom

    X
  • Published: August 13, 2008
  • DOI: 10.1371/journal.pone.0002921

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Correction: Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa

Roger H. Brookes, Philip C. Hill, Patrick K. Owiafe, Hannah B. Ibanga, David J. Jeffries, Simon A. Donkor, Helen A. Fletcher, Abdulrahman S. Hammond, Christian Lienhardt, Richard A. Adegbola, Helen McShane, ...
Correction | published 26 Feb 2011 | PLOS ONE
doi:10.1371/annotation/5284a0b6-62a9-484e-80a4-a08c59b3b17c